RehabCare Reports Third Quarter 2010 Results

RehabCare Group, Inc. (NYSE:RHB) today reported the following financial results.

Third Second Third Nine Months Ended Quarter Quarter Quarter September 30, Amounts in millions, except per share data

2010

2009

2010

2009

Consolidated Operating Revenues (a) $ 342.7 $ 334.0 $ 208.0 $ 1,004.1 $ 614.7 Consolidated Operating Earnings (a) 34.6 31.3 10.5 98.4 37.6 Consolidated Net Earnings from Continuing Operations (a),(b) 16.8 15.2 5.7 46.8 21.5 Loss from Discontinued Operations, Net of Tax (c)

(0.8 ) Consolidated Net Earnings (a),(b) 16.8 15.2 5.7 46.8 20.7

Net (Earnings) Loss Attributable to Noncontrolling Interests

(1.1 ) (0.5 ) 1.1 (1.4 ) 1.6 Net Earnings Attributable to RehabCare (a),(b) 15.7 14.7 6.8 45.4 22.3 Diluted Earnings per Share Attributable to RehabCare: Earnings from Continuing Operations, Net of Tax (a),(b) 0.64 0.59 0.37 1.84 1.28 Net Earnings (a),(b) 0.64 0.59 0.37 1.84 1.24 SRS Operating Revenues 130.9 130.9 123.4 388.1 370.3 SRS EBITDA 11.7 12.5 11.4 35.9 34.2 SRS Operating Earnings 10.4 11.1 9.8 31.8 29.4 HRS Inpatient Operating Revenues 32.6 31.8 32.9 95.5 97.6

HRS Outpatient Operating Revenues

13.0 13.0 12.1 38.1 35.6 HRS Operating Revenues 45.6 44.8 45.0 133.6 133.2 HRS EBITDA 9.1 8.4 8.8 25.0 24.0 HRS Operating Earnings 8.5 7.9 8.2 23.3 22.2 Hospital Operating Revenues (a) 166.2 158.4 39.7 482.4 111.2 Hospital EBITDA (a) 21.6 18.0 (5.9 ) 60.3 (9.0 ) Hospital Operating Earnings (Loss) (a) 15.7 12.3 (7.6 ) 43.2 (13.7 )

(a) During the 2010 second quarter, the Company recorded a $1.7 million unfavorable pretax revenue adjustment for estimates of additional amounts due on 2007 and 2008 cost reports for one of its inpatient rehabilitation facilities. The after-tax impact of this adjustment was approximately $1.0 million, or $0.04 per diluted share (see table on page 9).

(b) During the 2010 second quarter, the Company recognized a $0.8 million, or $0.03 per diluted share, income tax benefit for the combined impact of the reversal of a contingency reserve due to a favorable ruling from the Internal Revenue Service and tax credits identified during the quarter (see table on page 9).

(c) The $0.8 million after-tax loss from discontinued operations in the first nine months of 2009 included a $0.7 million loss on the sale of the Company’s Phase 2 Consulting business on June 1, 2009.

Management Comments

John H. Short, Ph.D, RehabCare President and Chief Executive Officer, commented, “While we are pleased that our legacy RehabCare hospitals exceeded expectations in the third quarter, we are focused on improving operations in underperforming Triumph hospitals. Key performance indicators of our combined operations are trending up, and we continue to expand our post-acute continuum of care through growth opportunities in select markets, two of which we are announcing today.”

“Our contract services divisions had a repeat performance of solid earnings,” Dr. Short said. “In our Skilled Nursing Rehabilitation Services division, we successfully reduced our percentage of patients being treated concurrently to 5% by the end of the third quarter, in advance of new concurrent therapy rules that went into effect October 1. Similar to the transition to PPS, the complex changes associated with MDS 3.0 and RUGs IV have caused some chaos in the skilled nursing facility market which will negatively impact margins in the fourth quarter.”

Financial Overview of Third Quarter

Consolidated operating revenues for the third quarter of 2010 were $342.7 million, which included $111.5 million generated by Triumph, a 64.7% increase compared to $208.0 million in the 2009 third quarter. Excluding Triumph, revenues increased $23.2 million, or 11.1%.

Consolidated net earnings from continuing operations attributable to RehabCare were $15.7 million, or $0.64 per diluted share, in the third quarter of 2010 compared to $6.8 million, or $0.37 per diluted share, in the prior year quarter. Earnings in the third quarter of 2009 included $2.2 million of pretax external merger and acquisition-related expenses, or $0.07 per diluted share after tax.

Operating revenues in the Skilled Nursing Rehabilitation Services (SRS) division increased 6.2% from $123.4 million in the third quarter of 2009 to $130.9 million in the third quarter of 2010, driven by a 4.3% increase in the average number of contract therapy programs operated. Contract therapy same store revenues increased 3.4%. Operating earnings were $10.4 million, or 7.9% of revenue, compared to $9.8 million, or 8.0% of revenue, in the third quarter of 2009.

On September 30, 2010, SRS operated in 1,131 locations compared to 1,115 locations at the end of the second quarter of 2010 and 1,098 locations at the end of the third quarter of 2009. SRS had 20 signed but unopened contracts at the end of the third quarter. Openings and closings in the quarter totaled 67 and 51, respectively, resulting in a net 16 additional units. Accordingly, the Company is revising its outlook for the full year 2010 from a net 50 to 75 new units to a net 10 to 20 new units.

The physician fee schedule and Medicare Part B therapy cap exceptions process are scheduled to expire on November 30 and December 31, 2010, respectively. Congress may extend both provisions, but due to the uncertainty of the mid-term elections, it is unclear as to whether this will occur before their deadlines. A decision on implementation of the Multiple Procedure Payment Reduction rule should be forthcoming soon.

The Hospital Rehabilitation Services (HRS) division’s 2010 third quarter operating revenues increased 1.2% to $45.6 million from $45.0 million in the third quarter of 2009. Inpatient operating revenues declined 1.0% as a result of a 2.6% decline in the average number of inpatient programs. Inpatient rehabilitation facility (IRF) same store revenues and discharges increased 3.3% and 4.7%, respectively, over the prior year quarter. Outpatient operating revenues increased 7.3% in the 2010 third quarter despite a 12.1% decline in the average number of outpatient programs. This was driven by a 22.2% improvement in average revenue per program including 8.0% same store growth in outpatient revenues. Operating earnings were $8.5 million, or 18.7% of revenue, compared to operating earnings of $8.2 million, or 18.2% of revenue, for the 2009 third quarter.

At September 30, 2010, the division operated 106 IRF programs, flat sequentially and down four from a year ago. The division had one IRF opening and one IRF closing, one subacute opening and two outpatient unit closings during the third quarter. At quarter end, the number of signed but unopened contracts was six, including three IRFs. The Company anticipates a net one to two new IRF programs for the fourth quarter.

Operating revenues in the Hospital division for the third quarter of 2010 increased $7.7 million, or 4.9%, sequentially to $166.2 million. Same store revenues increased $6.1 million, or 3.9% on a sequential basis, which included a second quarter unfavorable $1.7 million adjustment for estimated prior year cost report settlements at one IRF. Including this adjustment, the legacy RehabCare hospitals improved operating earnings by $5.2 million sequentially, a net improvement of $3.5 million.

Triumph generated revenues of $111.5 million, operating earnings of $12.9 million and EBITDA (earnings before interest, taxes, depreciation and amortization) of $16.9 million, or 15.2% of revenue, a sequential 1.5 percentage point decline, during the third quarter of 2010. The sequential decline primarily was related to operational issues at four hospitals. In addition, the progress of start-ups in Philadelphia and Houston Heights has been markedly slower than anticipated. Volumes increased, supported by the introduction of new clinical programs at several hospitals, and costs per patient day were reduced during the quarter.

At the end of the quarter, the Hospital division operated a total of 35 hospitals, including 29 long-term acute care hospitals (LTACHs) and six IRFs.

New Hospital Projects

Mishawaka, IN: RehabCare has signed a letter of intent with Saint Joseph Regional Medical Center in Mishawaka, IN, to form a joint venture that will own and operate Saint Joseph Rehabilitation Institute, with RehabCare acquiring a majority interest. The 40-bed IRF, now managed under an interim agreement by RehabCare, opened in December 2009 as an off-campus, distinct part unit of the acute care hospital. The joint venture partnership will seek to license and certify the facility as a freestanding IRF. RehabCare’s market presence also includes Triumph Hospital Our Lady of Peace, a 32-bed LTACH located on an additional campus of Saint Joseph’s. The Company expects to close on the agreement in the first quarter of 2011.

Houston, TX: RehabCare is developing a 46-bed IRF in northeast Houston. Scheduled for completion by the beginning of 2012, RehabCare will lease the approximately 56,000 square foot facility, which will feature all private patient rooms and state-of-the art therapy technologies. The RehabCare Houston market currently consists of 10 LTACHs, one owned IRF, one managed IRF and 27 skilled nursing facility programs.

Balance Sheet and Liquidity

At September 30, 2010, the Company had $22.5 million in cash and cash equivalents and $421.1 million in outstanding debt excluding unamortized original issue discounts. The Company has paid down debt by $43.0 million since the beginning of the year. Days sales outstanding (DSO) decreased sequentially to 61.9 days from 62.1 days.

For the nine months ended September 30, 2010, the Company generated cash from operations of $68.7 million and expended $23.5 million for capital expenditures, principally related to the start-up of Triumph hospitals in Philadelphia and Houston, upgraded services at several hospitals, companywide information systems and hospital facility maintenance capital.

Outlook

The Company does not provide revenue and earnings per share guidance, but provides the following outlook for the fourth quarter of 2010:

The Skilled Nursing Rehabilitation Services division expects 5.5% to 6.5% operating earnings margins and relatively flat unit growth in the fourth quarter. This outlook reflects the estimated impact of regulatory changes and the rollout of new information system technologies.
The Hospital Rehabilitation Services division expects 16% to 18% operating earnings margins, 2% to 4% year-over-year growth in IRF same store discharges and a net one to two new IRF programs for the fourth quarter.
The Hospital division, which includes both the legacy RehabCare and Triumph hospitals, expects combined fourth quarter revenue of $163 to $168 million and an EBITDA margin of approximately 14%.
The effective tax rate, after consideration of noncontrolling interests, is anticipated to be 38.25% for the remainder of the year.
The Company continues to expect DSO between 60 and 63 days.
Capital expenditures in the fourth quarter are anticipated to be $9 million, consisting of information systems investments, expansion projects and maintenance.

Conference Call Information

RehabCare will host a conference call on November 3, 2010, beginning at 10:00 AM Eastern time. Listeners may access the call by dialing (800) 640-9765, confirmation number 28163586, or in a listen-only mode through the Company’s website at http://www.rehabcare.com/about/investors/webcast.html. A replay of the call will be available beginning at approximately 3:00 PM Eastern time on November 3 by dialing (877) 213-9653, confirmation number 28163586. An online archive of the conference call will remain on the Company’s website through December 3, 2010.

About RehabCare Group

Established in 1982 and headquartered in St. Louis, MO, RehabCare (www.rehabcare.com) is a leading provider of post-acute care, owning and operating 35 long-term acute care and rehabilitation hospitals and providing program management services in partnership with over 1,270 hospitals and skilled nursing facilities in 42 states. RehabCare is included in the Russell 2000 and Standard and Poor’s Small Cap 600 Indices.

This press release contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based on the Company’s current expectations and could be affected by numerous factors, risks and uncertainties discussed in the Company’s filings with the Securities and Exchange Commission, including its most recent report on Form 10-K, subsequent quarterly reports on Form 10-Q and current reports on Form 8-K. Do not rely on forward-looking statements as the Company cannot predict or control many factors that affect its ability to achieve the results estimated. The Company makes no promise to update any forward-looking statements because of changes in underlying factors, new information, future events or otherwise.

This press release contains non-GAAP financial measures as such term is defined in Regulation G under the rules of the Securities and Exchange Commission. While the Company believes these non-GAAP financial measures are useful in evaluating the Company, this information should be considered as supplemental in nature and not as a substitute for or superior to the related financial information prepared in accordance with GAAP. Further, these non-GAAP financial measures may differ from similarly titled measures presented by other companies. The Company has included reconciliations of these non-GAAP measures to the most directly comparable GAAP measure in the tables of this release.

I. Condensed Consolidated Statements of Earnings

(Unaudited; amounts in thousands, except per share data) Three Months Ended Nine Months Ended Sept. 30, June 30, Sept. 30, Sept. 30, Sept. 30,

2010

2009

2010

2009

Operating revenues $ 342,730 $ 334,033 $ 208,040 $ 1,004,124 $ 614,735 Costs and expenses: Operating 273,390 267,299 169,647 801,759 492,500 Selling, general and administrative 26,872 27,814 24,186 81,221 73,254 Depreciation and amortization 7,866 7,642 3,727 22,788 11,379 Total costs and expenses 308,128 302,755 197,560 905,768 577,133 Operating earnings 34,602 31,278 10,480 98,356 37,602 Interest income 32 28

78 19 Interest expense (8,250 ) (8,551 ) (498 ) (25,301 ) (1,619 ) Other income (expense), net 5 (5 ) 3 7 4 Equity in net income of affiliates 114 211 52 441 326 Earnings from continuing operations before income taxes 26,503 22,961 10,037 73,581 36,332 Income tax expense 9,725 7,744 4,331 26,757 14,799 Earnings from continuing operations 16,778 15,217 5,706 46,824 21,533 Loss from discontinued operations

(16 )

(847 ) Net earnings 16,778 15,217 5,690 46,824 20,686 Net (earnings) loss attributable to noncontrolling interests (1,079 ) (512 ) 1,067 (1,427 ) 1,614 Net earnings attributable to RehabCare $ 15,699 $ 14,705 $ 6,757 $ 45,397 $ 22,300 Amounts attributable to RehabCare: Earnings from continuing operations $ 15,699 $ 14,705 $ 6,773 $ 45,397 $ 23,147 Loss from discontinued operations

(16 )

(847 ) Net earnings $ 15,699 $ 14,705 $ 6,757 $ 45,397 $ 22,300 Diluted EPS attributable to RehabCare: Earnings from continuing operations $ 0.64 $ 0.59 $ 0.37 $ 1.84 $ 1.28 Loss from discontinued operations

(0.04 ) Net earnings $ 0.64 $ 0.59 $ 0.37 $ 1.84 $ 1.24 Weighted average diluted shares 24,715 24,766 18,282 24,692 18,050

II. Condensed Consolidated Balance Sheets

(Amounts in thousands) Unaudited September 30, December 31,

2010

2009

Assets Cash and cash equivalents $ 22,465 $ 24,690 Accounts receivable, net 220,393 199,447 Deferred tax assets 18,640 21,249 Other current assets 16,681 19,530 Total current assets 278,179 264,916 Property and equipment, net 119,274 111,814 Goodwill 566,078 566,078 Intangible assets 129,155 135,406 Investment in unconsolidated affiliate 4,868 4,761 Other assets 24,976 27,005 $ 1,122,530 $ 1,109,980 Liabilities & Equity Current portion of long-term debt $ 14,284 $ 7,507 Payables & accruals 149,541 144,113 Total current liabilities 163,825 151,620 Long-term debt, less current portion 398,922 447,760 Other non-current liabilities 54,290 50,980 Stockholders’ equity 484,544 437,338 Noncontrolling interests 20,949 22,282 $ 1,122,530 $ 1,109,980

III. Condensed Consolidated Statements of Cash Flows

(Unaudited; amounts in thousands) Nine Months Ended September 30,

2010

2009

Net cash provided by operating activities $ 68,739 $ 46,623 Net cash used in investing activities (23,824 ) (9,918 ) Net cash used in financing activities (47,140 ) (29,537 ) Net increase (decrease) in cash and cash equivalents (2,225 ) 7,168 Cash and cash equivalents at beginning of period 24,690 27,373 Cash and cash equivalents at end of period $ 22,465 $ 34,541

Supplemental information:

Additions to property and equipment $ (23,489 ) $ (8,932 )

IV. Operating Statistics (Unaudited; dollars in thousands)

Third Second Third Nine Months Ended Quarter Quarter Quarter September 30,

2010

2009

2010

2009

Skilled Nursing Rehabilitation Services

Operating revenues $ 130,943 $ 130,851 $ 123,350 $ 388,146 $ 370,285 Operating expenses 107,067 105,655 99,631 316,055 298,763 Selling, general and administrative 12,138 12,717 12,321 36,222 37,305 Depreciation and amortization 1,385 1,365 1,564 4,057 4,820 Operating earnings $ 10,353 $ 11,114 $ 9,834 $ 31,812 $ 29,397 Operating earnings margin 7.9 % 8.5 % 8.0 % 8.2 % 7.9 % EBITDA $ 11,738 $ 12,479 $ 11,398 $ 35,869 $ 34,217 Average number of contract therapy locations 1,136 1,127 1,089 1,131 1,077 End of period number of contract therapy locations 1,131 1,115 1,098 1,131 1,098 Patient visits (in thousands) 2,054 2,080 2,011 6,154 6,033

Hospital Rehabilitation Services

Operating revenues Inpatient Rehabilitation Facility (IRF) $ 30,144 $ 29,609 $ 31,092 $ 88,769 $ 92,367 Subacute 2,454 2,125 1,834 6,673 5,221 Total Inpatient $ 32,598 $ 31,734 $ 32,926 $ 95,442 $ 97,588 Outpatient 13,003 13,000 12,113 38,133 35,614 Total HRS $ 45,601 $ 44,734 $ 45,039 $ 133,575 $ 133,202 Operating expenses 32,470 31,856 31,451 95,481 93,092 Selling, general and administrative 4,040 4,445 4,831 13,112 16,127 Depreciation and amortization 543 556 561 1,636 1,831 Operating earnings $ 8,548 $ 7,877 $ 8,196 $ 23,346 $ 22,152 Operating earnings margin 18.7 % 17.6 % 18.2 % 17.5 % 16.6 % EBITDA $ 9,091 $ 8,433 $ 8,757 $ 24,982 $ 23,983 Average number of programs IRF 106 104 111 105 112 Subacute 11 10 9 10 9 Total Inpatient 117 114 120 115 121 Outpatient 31 32 36 31 36 Total HRS 148 146 156 146 157 End of period number of programs IRF 106 106 110 106 110 Subacute 11 10 9 11 9 Total Inpatient 117 116 119 117 119 Outpatient 30 32 35 30 35 Total HRS 147 148 154 147 154 IRF discharges 10,473 10,376 10,858 30,856 33,216 Outpatient visits (in thousands) 274 279 320 815 959

IV. Operating Statistics Continued (Unaudited; dollars in thousands)

Third Second Third Nine Months Ended Quarter Quarter Quarter September 30,

2010

2009

2010

2009

Hospitals

Operating revenues $ 166,186 $ 158,448 $ 39,651 $ 482,403 $ 111,248 Operating expenses 133,853 129,788 38,565 390,223 100,645 Selling, general and administrative 10,694 10,652 7,034 31,887 19,568 Depreciation and amortization 5,938 5,721 1,602 17,095 4,728 Operating earnings (loss) $ 15,701 $ 12,287 $ (7,550 ) $ 43,198 $ (13,693 ) Operating earnings margin 9.4 % 7.8 % -19.0 % 9.0 % -12.3 % EBITDA $ 21,639 $ 18,008 $ (5,948 ) $ 60,293 $ (8,965 )

LTACHs

Number of hospitals – end of period 29 29 7 29 7 Available licensed beds – end of period 1,605 1,605 353 1,605 353 Admissions 3,754 3,522 775 10,839 1,812 Patient days 96,424 92,854 18,368 279,733 46,798 Average length of stay (Medicare days only) 25 26 24 26 26 Net inpatient revenue per patient day $ 1,513 $ 1,514 $ 1,157 $ 1,515 $ 1,191 Occupancy rate 65 % 64 % 60 % 64 % 63 % Percent patient days - Medicare 74 % 72 % 66 % 73 % 71 %

IRFs

Number of hospitals – end of period 6 6 6 6 6 Available licensed beds – end of period 243 243 243 243 243 Admissions 1,241 1,157 1,179 3,630 3,627 Discharges 1,210 1,197 1,169 3,595 3,569 Average length of stay (Medicare days only) 13 12 13 13 12 Net inpatient revenue per discharge (a) $ 14,658 $ 12,718 $ 14,053 $ 14,074 $ 13,968 Occupancy rate 72 % 69 % 68 % 71 % 69 % Percent patient days - Medicare 63 % 62 % 67 % 64 % 66 % (a) Excluding a $1.7 million unfavorable prior year cost report adjustment recorded during the second quarter of 2010 for one of the Company’s IRFs, net inpatient revenue per discharge for IRFs would have been $14,134 in the second quarter of 2010. V. Charges/Credits Included in Statement of Earnings

(Amounts in thousands, except per share data)

Second Quarter 2010

Third Quarter 2009

Pre-Tax

Impact

After-Tax

Impact

Diluted

EPS

Pre-Tax

Impact

After-Tax

Impact

Diluted

EPS

Unfavorable cost report adjustment $ 1,696 $ 1,047 $ 0.04

Favorable income tax adjustments

(842 ) (0.03 )

External merger and acquisition-related costs

$ 2,227 $ 1,358 $ 0.07 $ 1,696 $ 205 $ 0.01 $ 2,227 $ 1,358 $ 0.07

VI. Operating Earnings and EBITDA Reconciliation

Third Second Third Nine Months Ended Quarter Quarter Quarter September 30,

2010

2009

2010

2009

Net earnings $ 16,778 $ 15,217 $ 5,690 $ 46,824 $ 20,686 Income tax expense 9,725 7,744 4,331 26,757 14,799 Interest income (32 ) (28 )

(78 ) (19 ) Interest expense 8,250 8,551 498 25,301 1,619 Other (income) expense, net (5 ) 5 (3 ) (7 ) (4 ) Equity in net income of affiliates (114 ) (211 ) (52 ) (441 ) (326 ) Loss from discontinued operations

847 Operating earnings 34,602 31,278 10,480 98,356 37,602 Depreciation and amortization 7,866 7,642 3,727 22,788 11,379 Consolidated EBITDA $ 42,468 $ 38,920 $ 14,207 $ 121,144 $ 48,981 SRS operating earnings $ 10,353 $ 11,114 $ 9,834 $ 31,812 $ 29,397 SRS depreciation and amortization 1,385 1,365 1,564 4,057 4,820 SRS EBITDA $ 11,738 $ 12,479 $ 11,398 $ 35,869 $ 34,217 HRS operating earnings $ 8,548 $ 7,877 $ 8,196 $ 23,346 $ 22,152 HRS depreciation and amortization 543 556 561 1,636 1,831 HRS EBITDA $ 9,091 $ 8,433 $ 8,757 $ 24,982 $ 23,983 Hospital operating earnings (loss) $ 15,701 $ 12,287 $ (7,550 ) $ 43,198 $ (13,693 ) Hospital depreciation and amortization 5,938 5,721 1,602 17,095 4,728 Hospital EBITDA $ 21,639 $ 18,008 $ (5,948 ) $ 60,293 $ (8,965 )

Rehabcare (NYSE:RHB)
Historical Stock Chart
From Jun 2024 to Jul 2024